Lorista H – a combination of losartan and hydrochlorothiazide for dual blood pressure control. 28 tablets.
Losartan, Hydrochlorothiazide
Lorista H
Cardiovascular System → Antihypertensive Agents → Combination Agents → Preparations Containing an Angiotensin II Receptor Antagonist and a Diuretic
Each film-coated tablet contains:
Active ingredients: Losartan potassium 50 mg, hydrochlorothiazide 12.5 mg.
Excipients: Pregelatinized starch, microcrystalline cellulose, lactose monohydrate, magnesium stearate, hypromellose, macrogol 4000, quinoline yellow (E104), titanium dioxide (E171), talc.
Angiotensin II receptor antagonist in combination with a diuretic.
ATC code: C09DA01.
Arterial hypertension (in patients for whom combination therapy is indicated).
The usual initial and maintenance dose of Lorista H is 1 tablet once daily.
In case of an insufficient therapeutic response, the dose may be increased to 2 tablets once daily. The dose is selected according to the reduction in blood pressure achieved after 3 weeks of treatment.
The maximum recommended dose of Lorista H is 2 tablets per day.
Dosage in renal impairment: Patients with mild renal impairment (creatinine clearance greater than 0.5 mL/sec and/or 30 mL/min) may be prescribed the usual dose.
The medicine is not recommended for patients with severe renal impairment or those undergoing hemodialysis.
Since the recommended initial dose of losartan in patients with hypovolemia is 25 mg once daily, treatment with Lorista H should be initiated after discontinuation of diuretics and correction of hypovolemia.
The medicine may be taken with or without food. To avoid missing a dose, the tablets should be taken every day at the same time.
If a patient forgets to take the medicine, the next dose should not be doubled. At the next scheduled administration, the usual dose should be taken at the prescribed time.
The duration of treatment is not limited.
.png)
